- Nate Serg
Lab Rat Island
Updated: Sep 17, 2021
Correct language is ‘critical’: Not COVID-19 ‘vaccines,’ but experimental biological agents. It means you have enrolled yourself in a medical trial …
(“87,000 Doctors & Nurses Refuse COVID19 Vaccine." Just in the Nethelands alone.)
The new Covid vaccines will make billions of dollars for the big pharmaceutical companies, but here’s what they won’t do:
The vaccines will not cure Covid
The vaccines will not prevent people from contracting Covid
The vaccines will not prevent Covid-related hospitalizations
The vaccines will not prevent Covid-caused deaths
Now, I know what you’re thinking. You’re thinking, “If the vaccine does not protect me from getting Covid (or dying from Covid), then why should I take it?”
And the answer is: “You shouldn’t. It makes no sense at all, especially in view of the fact that new vaccines pose considerable risks to one’s health and well-being.
https://principia-scientific.com/heres-why-you-should-skip-the-covid-vaccine/
In early April 2021 the CDC director admitted the covid experimental biological agents "vaccine" does not make on less contagious. (if such a thing existed to prevent) In addition to multiple stories of PCR positive test after "fully vaccinated".
13,627 Post-COVID Vaccine Reported Deaths
55,821 Post-COVID Vaccine Reported Hospitalizations
623,341 COVID Vaccine Adverse Event Reports
Data released ...
show that between Dec. 14, 2020 and July 2, 2021, a total of 438,441 total adverse events were reported to VAERS, including 9,048 deaths — an increase of 2,063 over the previous week. There were 41,015 serious injury reported during the same time period — up 6,950 compared with last week. In the U.S, 328.9 million COVID vaccine doses had been administered as of July 2. This includes: 134 million doses of Moderna’s vaccine, 182 million doses of Pfizer and 13 million doses of the Johnson & Johnson (J&J) COVID vaccine.
Of the 9,048 deaths reported as of July 2, 22% occurred within 48 hours of vaccination, 15% occurred within 24 hours and 37% occurred in people who became ill within 48 hours of being vaccinated.
This week’s data for 12- to 17-year-olds show: 13,385 total adverse events, including 801 rated as serious and 14 reported deaths among 12- to 17-year-olds. Two of the nine deaths were suicides.
The most recent reported death includes a 13-year-old boy (VAERS I.D. 1431289) with a previous history of COVID who suffered cardiac arrest and died 17 days after vaccination with Pfizer.
Other reports include a 13-year-old boy (VAERS I.D. 1406840) who died two days after receiving a Pfizer vaccine, three 15-year-olds (VAERS I.D. 1187918, 1382906 and 1242573), four 16-year-olds (VAERS I.D. 1420630, 1426828, 1225942 and 1386841) and three 17-year-olds (VAERS I.D. 1199455, 1388042 and 1420762).
1,934 reports of anaphylaxis among 12- to 17-year-olds with 99% of cases attributed to Pfizer’s vaccine, 1.1% to Moderna and 0.2% (or four cases) to J&J. 347 reports of myocarditis and pericarditis (heart inflammation) with 343 attributed to Pfizer’s vaccine.
57 reports of blood clotting disorders, 56 attributed to Pfizer and 1 attributed to Moderna. This week’s total VAERS data, from Dec. 14, 2020 to July 2, 2021, for all age groups show: 22% of deaths were related to cardiac disorders. 50% of those who died were male, 45% were female and the remaining death reports did not include gender of the deceased.
The average age of death was 74.7.
As of July 2, 2,678 pregnant women reported adverse events related to COVID vaccines, including 994 reports of miscarriage or premature birth.
Of the 4,456 cases of Bell’s Palsy reported, 59% were attributed to Pfizer vaccinations, 39% to Moderna vaccine and 7% to J&J.
398 reports of Guillain-Barré Syndrome, with 47% of cases attributed to Pfizer, 40% to Moderna and 19% to J&J.
121,092 reports of anaphylaxis with 46% of cases attributed to Pfizer’s vaccine, 46% to Moderna and 7% to J&J. 8,256 reports of blood clotting disorders. Of those, 3,959 reports were attributed to Pfizer, 2,699 reports to Moderna and 1,552 reports to J&J.
1,796 cases of myocarditis and pericarditis with 1,177 cases attributed to Pfizer, 563 cases to Moderna and 52 cases to J&J’s COVID vaccine.
COVID Jab: More Vaccine Deaths Than Past 15 Years COMBINED: Brian Shilhavy
30,305 people died within 21 days of having a Covid-19 Vaccine in England during the first 6 months of 2021 according to ONS data
Remember, Fewer Than ONE PERCENT Of Vaccine Injuries Are Reported To The CDC, ACCORDING TO A HARVARD STUDY
If only 1% are reported, there may be around 155,100 deaths, and vaccines may be killing 0.28% of all who get them. Again, while any and all deaths following COVID-19 vaccination are supposed to be reported, it’s still unclear whether mandatory reporting is actually taking place.
While 0.0028% or even 0.28% might not seem like a shockingly high percentage of deaths, it’s hard to justify even a single death of a young and healthy individual. For comparison, the overall noninstitutionalized infection fatality ratio from COVID-19, for all age groups, is 0.26%. Those under 40 have only a 0.01% risk of dying from COVID-19 if infected.
As of July 9, reported deaths in the VAERS totaled 10,991. Of those, 4,593 occurred within 72-hours of vaccination.
The actual efficacy of Moderna Synthetic Gene Therapy
There are many issues with the trial data, and design. It must be noted that PCR tests are not fit for purpose and without Sanger sequencing we have no idea how many of these people actually had “Covid” vs another respiratory virus or something else. This is a preeminent reason why Dr Yeadon and Dr Wodarg filed a Stay of Action on the vaccine trials. As Dr Peter Doshi, Associate Editor of BMJ highlighted, access to the raw data is required to further elucidate the areas of concern: With 20 times more suspected covid-19 than confirmed covid-19, and trials not designed to assess whether the vaccines can interrupt viral transmission, an analysis of severe disease irrespective of etiologic agent—namely, rates of hospitalizations, ICU cases, and deaths amongst trial participants—seems warranted, and is the only way to assess the vaccines’ real ability to take the edge off the pandemic.” Approximately 5-6 symptoms listed as “side effects” are the same as Covid symptoms. Pfizer/BioNtech only started counting “cases” one week after the second dose, and Moderna, 2 weeks after the second dose. Therefore, if these side effects were labelled as “Covid” symptoms instead, even the paltry efficacy of about 1% would be relegated into the negative integers. In others words, the injected group may have been sicker with “Covid” more than the placebo group. There have been many critiques of the applicability of the limited data to the general populace, especially the vulnerable elderly.
An important analysis of this was done by Dr James Lyons-Weiler who discovered the general population is dying at a rate 6.3 times the rate of participants in the Moderna trial (including placebo and injection groups). If Moderna’s on-vaccine death rate is so far below the national death rate and also simultaneously more than five times greater than Pfizer’s on-vaccine death rate, then Pfizer’s study sample appears even less representative of the entire population. This, too, requires due consideration.” An integral question as to whether Pfizer/BioNtech and Moderna recruited supermen and women for their trials, comes to mind.
The incidence of “severe” Covid in Placebo groups which scrutinizing the details, wasn’t necessarily severe presentation, is so low that trials of 30,000-40,000 lacked statistical power to determine reductions in hospitalizations and deaths, according to Tal Zaks, CMO Moderna. Zaks is correct, the incidence of severe “Covid” was only 0.04% in Pfizer/BioNtech and 0.22% in Moderna. Due to this very low attack rate of severe presentation in the population, the absolute risk reduction in severe presentation, even taking data at face value, is nominal.
Therefore, potential SGT recipients must be informed that to reduce “severe” presentation, chances are over 99.5% that these synthetic gene therapies will not work. The British Medical Journal has reported: Hospital admissions and deaths from covid-19 are simply too uncommon in the population being studied for an effective vaccine to demonstrate statistically significant differences in a trial of 30 000 people.
The same is true of its ability to save lives or prevent transmission: the trials are not designed to find out.” To convey informed consent, the side effect profile must also be considered. Up to 80% of injected trial recipients experienced side effects, in a setting for a nebulous syndrome where 80% of people are asymptomatic. The incidences of immediate side effects in both trials were significant and dwarfed the absolute risk reduction in both the primary efficacy endpoints, as well as for “severe” Covid. For example, for Moderna 81.9% experienced any systemic reaction. Grade 3 reactions (considered severe) were experienced by 17.4%. This is 79X more likely than the incidence of severe Covid in the Moderna group. (17.4/.22=79X) Based on preliminary reports of adverse events [emphasis added]:
This is an injury rate of 1 in every 40 jabs. This means that the 150 shots necessary to avert one mild case of COVID (1-2 cold symptoms) will cause serious injury to at least three people.“
The safety data for both companies is approximately only two months before receiving emergency use authorization status. Therefore, there is no data for mid-long term side effects, as the trials are ongoing. The estimated completion date for Pfizer/BioNtech trials is Jan 31, 2023. The estimate completion date for Moderna trials is October 27, 2022. According to the data, and elaborated by Tal Zaks (CMO of Moderna) the trials are not designed to demonstrate a reduction in transmission, due to “operational realities”. It is therefore baffling how medical doctors and public health officials are proclaiming these SGTs will promote herd immunity. The manufacturers have also made it clear that efficacy beyond 2 months or so is unknown. Therefore, the 1% absolute risk reduction in mild/moderate, cold/flu symptoms may not last more than a few months.
It appears evident mainstream media blast misleading headlines that are not able to be backed up by the "evidence:"
HEADLINE: Nearly all COVID deaths in US are now among unvaccinated
Yet these two statements were included in the actual article:
"The AP ANALYZED FIGURES provided by the Centers for Disease Control and Prevention. The CDC itself HAS NOT ESTIMATED what percentage of hospitalizations and deaths are in fully vaccinated people, CITING LIMITATIONS IN THE DATA.
Among them: ONLY ABOUT 45 STATES REPORT BREAKTHROUGH INFECTIONS, and some are MORE AGGRESSIVE THAN OTHERS in looking for such cases. SO THE DATA PROBABLY UNDERSTATES SUCH INFECTIONS, CDC officials said."
https://www.yahoo.com/news/nearly-covid-deaths-us-now-154100375.html
So the Associated Press decided to crunch the numbers of limited, admittedly inaccurate data to create headlines to advertise for a rushed, experimental "vaccination" campaign that has so far had over 13,627 Post-COVID Vaccine Reported Deaths Vaccine. Adverse Event Reports and deaths also underreported/undercounted, and now addition of warning labels for blood clots and heart inflammation.
And the CDC admitted to not tracking all vaccination breakthrough cases May 1st, 2021 and also cited inaccurate data back then:
"THE NUMBER OF COVID-19 VACCINE BREAKTHROUGH INFECTIONS REPORTED TO CDC LIKELY ARE AN UNDERCOUNT OF ALL SARS-CoV-2 INFECTIONS AMONG FULLY VACCINATED PERSONS. National surveillance RELIES ON PASSIVE AND VOLUNTARY REPORTING, AND DATA MIGHT NOT BE COMPLETE OR REPRESENTATIVE. These surveillance data are a snapshot and help identify patterns and look for signals among vaccine breakthrough cases."
https://www.cdc.gov/vaccines/covid-19/health-departments/breakthrough-cases.html
Why anyone has any trust left in the MSM and the CDC at this point is beyond me.
Their See through. The information is there when you read past the headlines.
Mike
CONCERNING THE CLAIM UNVAXXED ARE FILLING HOSPITALS
1- It would seem their numbers are manipulted, by counting anyone that's not 14 days post final shot (2nd regimen for Pfizer/Moderna and Single for J&J) as "unvaccinated".
This means you could have had your second Moderna shot 13 days and 23 hours ago but if you're admitted with "Covid like symptoms" (which I'm sure we can all agree could be caused by injecting yourself with ...) then you count as "unvaccinated" and go into their stats as such.
See the problem here?
"....and unvaccinated <14 days receipt of the first dose of a 2-dose series or 1 dose of the single-dose vaccine or if no vaccination registry data were available..."
https://www.cdc.gov/mmwr/volumes/70/wr/mm7034e5.htm?s_cid=mm7034e5_w
SO YES. These hospitalizations will be considered unvaxxinated.
The average person would define "unvaccinated" as having had Zero shots ever.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated.html
Observed the 14-day trick in the trials, used it to downsize jab reactions by calling it latent covid.
2. Hospitals are not required to report to the CDC hospitalization of vaccinated persons.
"DSHS doesn’t track the number of COVID-19 hospitalizations among vaccinated people statewide because hospitals are not required to report that information"
BUT SOMEHOW they can say "all new COVID-19 cases and hospitalizations in the area have been among unvaccinated people." - ...
https://www.texastribune.org/2021/07/21/coronavirus-texas-vaccinated-deaths/
BY calling people that have been injected with just one or 2 does unvaccinated or even partially vaccinated, for any reason, takes the blame off the drug of any onset illness or hospitalization. (Partialy: after shot or shots but not considered vaccinated due to when they think it should be working)
DEMOGRAPHICS ARE NOT CONSIDERED:
If a particular town or city has low vaccination rates, the hospitals are likely to represent that common feature. There will be more of any demographic that represents an inequality in an areas demographics.
CONCERNING "CASE" #'S
1. The CDC stopped recording "breakthrough" "infections" months ago.
Top epidemiologist: CDC undercounting vaccinated COVID cases
https://www.wnd.com/2021/07/top-epidemiologist-cdc-undercounting-vaccinated-covid-cases/?fbclid=IwAR0Lwa0ra-5a8goArx9oZC4wrHjapnfUimU9iflmNtCcoGsS0ozOeRhEqAs
2. "Vaccinated" people are not tested as often
Deaths reported as of March 6, 30% occurred within 48 hours of vaccination, and 46% occurred in people who became ill within 48 hours of being vaccinated.
....As of March 5, 265 pregnant women had reported adverse events related to COVID vaccines, including 85 reports of miscarriage or premature birth. THAT NUMBER was nearing 1000 last month.
None of the COVID vaccines approved for Emergency Use Authorization (EUA) have been tested for safety or efficacy in pregnant women.
Just in March there were 1,689 reports of anaphylaxis, with 59% of cases attributed to the Pfizer-Bio-N-Tech vaccine and 41% to Moderna.
As of July 9, reported deaths in the VAERS totaled 10,991. Of those, 4,593 occurred within 72-hours of vaccination.
America’s Frontline Doctors (AFLDS) filed a motion July 19, seeking immediate injunctive relief in Alabama Federal District Court to stop the use of Emergency Use Authorization (EUA) COVID vaccines — Pfizer/BioNTech, Moderna and Johnson & Johnson (J&J) — for three groups of Americans.
Trials Rigged To Pass Efficacy Test
..when it comes to the COVID-19 vaccine, shockingly, preventing infection is not a criterion for success in any of these trials. The only criterion for a successful COVID-19 vaccine is a reduction of COVID-19 symptoms, and even then, the reduction required is minimal.
..“For Moderna, the initial interim analysis will be based on the results of infection of only 53 people. The judgment reached in interim analysis is dependent upon the difference in the number of people with symptoms … in the vaccinated group versus the unvaccinated group. Moderna’s success margin is for 13 or less of those 53 to develop symptoms compared to 40 or more in their control group.”
The other vaccine makers are basing results on a similar protocol, where only a limited number of vaccinated participants are exposed to the virus to evaluate the extent of their symptoms. Johnson & Johnson’s interim analysis will include results from 77 vaccine recipients who have been infected with SARS-CoV-2, and if fewer than 18 of them develop symptoms of COVID-19, compared to 59 in the control group, the vaccine will be considered successful.
In AstraZeneca’s case, the interim analysis includes 50 vaccine recipients. The vaccine will be a success if 12 or fewer develop symptoms after exposure to SARS-CoV-2, compared to 19 in the 25-person control group.
Pfizer’s interim analysis is the smallest of the bunch, with just 32 vaccine recipients. Their success margin is seven or fewer vaccine recipients developing symptoms, compared to 25 in the control group. In the primary analysis, efficacy is set to about 60%, and at most, 164 volunteers will be included in that analysis.
Especially concerning are that those receiving the vaccine in these trials are young and healthy individuals who are not really at high risk of dying from COVID-19. This makes the results of these trials highly questionable in the far more vulnerable population of the elderly.
…..Trials Are Merely Testing Reduction Of Common Cold Symptoms
As if that’s not eyebrow-raising enough, the minimum qualification for a “case of COVID-19” amounts to just one positive PCR test and one or two mild symptoms, such as headache, fever, cough or mild nausea. As noted by Haseltine, “This is far from adequate.”
All they’re doing is testing to see if this COVID-19 vaccine will minimize common cold symptoms. They are not actually ensuring the vaccine will prevent serious COVID-19 complications.
Severe illness and death are also secondary objectives in these trials, and none of them include failure to prevent hospitalization or death as an important barrier to success. ….. the vaccine cannot reduce infection, hospitalization or death, then it cannot end the pandemic, which means everyone who takes the vaccine will be doing so in vain…..
AstraZeneca is using injected meningococcal vaccine rather than a true placebo.6 ……Another way AstraZeneca is masking potential side effects is by administering the vaccine along with certain drugs. In one of its study arms, subjects are given acetaminophen every six hours for the first 24 hours after inoculation.
….after the first of two doses of the Moderna COVID-19 vaccine, 80% of Phase 1 participants receiving the 100 microgram (mcg) dose developed systemic side effects.21
After the second dose, 100% reported side effects ranging from fatigue (80%), chills (80%), headache (60%) and myalgia or muscle pain (53%).
Despite that, the 100-mcg dose was ultimately chosen to move on to Phase 3 trials.22 In the highest dosage group, which received 250 mcg, 100% of participants suffered side effects after both the first and second doses.23 Three of the 14 participants (21%) in the 250-mcg group suffered “one or more severe events.”
Euro Database Shows over 20,000 deaths from the jabs last month
What Vaccine Trials? Published on January 7, 2021 Written by Iain Davis
People genuinely appear to believe that the COVID 19 vaccines have undergone clinical trials and have been proven to be both safe and effective. That belief is simply wrong.
…..If you decide to have Pfizer and BioNTech’s experimental mRNA-based BNT162b2 (BNT) vaccine, or any other claimed COVID 19 vaccine for that matter, you are a test subject in a drug trial.……
When investigator Fran Leader questioned Pfizer they confirmed:
The DNA template does not come directly from an isolated virus from an infected person…”
….This was an interim analysis funded by, among others, CEPI and the Bill and Melinda Gates Foundation. The analysis was based upon trials which are years from completion and haven’t reported anything. The researchers also stated:
There were no peer-reviewed publications available on efficacy of any severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines…
There is no clear scientific evidence establishing either the safety or efficacy of proposed COVID 19 vaccines..
The 1,2,3 phase trial for AZD1222 was registered with the U.S. Centre for Disease Control as clinical trial NCT04516746 [Archived 29th December 2020]. It is incomplete and the estimated end date is February 21st 2023. The CDC state:
No Study Results Posted
Astrazeneca are years away from reporting any “final data.” It is impossible for the UK Department of Health to review it, because it doesn’t exist.
…
the Medicines and Healthcare products Regulatory Agency (MHRA) state:
“This medicinal product does not have a UK marketing authorization…”
The fact that there are no completed clinical trials for the Pfizer and BioNTech BNT vaccine also explains why the FDA State:
“Additional adverse reactions, some of which may be serious, may become apparent with more widespread use of the Pfizer-BioNTech COVID-19 Vaccine….”
The FDA also noted:
“[There is]…currently insufficient data to make conclusions about the safety of the vaccine in sub-populations such as children less than 16 years of age, pregnant and lactating individuals, and immunocompromised individuals…..[the] risk of vaccine-enhanced disease over time, potentially associated with waning immunity, remains unknown…”
….. 95% effective claim. However, this was based upon relative risk reduction. That is the declared percentage difference between the vaccinated group’s 8/18310 chance (0.044%) of developing COVID 19 against a 162/18319 (0.88%) chance of COVID 19 symptoms without the vaccine. As this larger group of 43,000 people have yet to be trialled, there is no basis for this claimed outcome. But it is what it is, and we can use these reported figures here.
It should be noted this only refers to an alleged reduction of COVID 19 symptoms among those who have the virus. The tested endpoints do not demonstrate that the vaccine will either reduce the spread of infection or save lives. It should also be noted that these figures suggest the threat from COVID 19 is vanishingly small.
Using Pfizer’s figures, the relative risk reduction is 100(1 – (0.044/0.88)). Which is 95%. Voila!
… The absolute risk of developing COVID 19 symptoms without the vaccine is supposedly 0.88% and with the vaccine 0.044%. In absolute terms, the effectiveness of the vaccine is (0.88-0.044)%.
…..A risk reduction of 0.84%. Oh! A barely perceptible “efficacy.”
To this day, there are no clinical trial results.
… archived ClinicalTrials.gov web-page, the Study Results tab reads “No Results Posted.” That is because there are no posted or submitted results from the Pfizer BioNTech trial of the BNT162b2 vaccine: “No Study Results Posted on ClinicalTrials.gov for this Study…”
Mainstream media reports, giving the impression that these vaccines have been found to be effective and safe are not evidence and they are not based on science. They are based on political policy and they report dangerous pseudo-scientific babble, masquerading as science journalism. ….
FDA by Pfizer and BioNTech, this indicates a broad population based mortality risk from COVID 19 of 1.4(0.88/100) which is 0.012%.
Please bear this incredibly remote risk in mind as we discuss the early indication of the apparent threat to public health presented by the mRNA vaccine.
“Health Impact Events” (HIE) reveal a worrying level of adverse reactions from the mRNA vaccine. The CDC define an HIE as:
“Unable to perform normal daily activities, unable to work, required care from doctor or health care professional..”
This is an HIE rate of 2.8%.... ( Compared to 0.012%.)
“Unable to perform normal daily activities, unable to work, required care from doctor or health care professional…”
As it is the most vulnerable who are the first to receive this vaccine, given the tiny risk of mortality from the COVID 19 disease, it is by no means clear that this is a risk worth taking.
…frame for Pfizer to assess serious adverse events (SAE’s) is “6 months after last dose.” This is the minimum term for assessing SAE’s in phase one of the trial.
The threat of COVID 19, though tiny overall, is statistically zero for those aged 18-55. Those with any measurable risk from COVID 19 were in the older age group.
the results, even from this practically inconsequential effort, suggest the risk from the vaccine is greater than the risk presented by COVID 19. By a considerable margin.
COVID 19 is only an appreciable risk for the most vulnerable in society. It is a risk to the infirm elderly and people with existing life threatening conditions.
If we look at the exclusion criteria for Phase One, these people were not in the cohort tested. Anyone with high blood pressure, asthma, diabetes or a high BMI were excluded from the alleged safety trial. But the vaccine is being given to the most vulnerable first.
Of the 39 older people at most risk in the phase one study, none of them had the serious comorbidities which the overwhelming majority of those who die “with” COVID 19 possess. The people actually at risk from COVID 19 nominally entered the BNT trials at phase 2 and 3. However, it appears every effort has been made to limit, if not completely remove, their number too. “Immunocompromised or individuals with known or suspected immunodeficiency,” were excluded.
The people with the comorbidities associated with so called COVID 19 deaths were practically ruled out from the BNT vaccine trials.
….
there are no reported results from either phase 2 or 3. No one has the faintest idea what the health risks of BNT are, especially for those it is supposedly designed to protect,….
They do so after the manufacturers failed to properly test its safety on a 39 people who were in the at risk group but did not have the comorbidity that leads to claimed COVID 19 deaths.
RISK REDUCTION
CDC PRESENTATION
statistically zero for those aged 18-55
https://web.archive.org/web/20201029012809/https://www.nejm.org/doi/full/10.1056/NEJMoa2027906#close
______________________________________________________________________
TRIALS WHAT TRIALS?
"Truly striking.” “Tremendous.” “Extraordinary.” “Miraculous.” “A great day for science and humanity.” Those are just a few of the hyperbolic responses from government health officials and Big Pharma cheerleaders to preliminary COVID vaccine trial data released by Pfizer and Moderna this past week...."
"If it all sounds too good to be true, then congratulations: Your B.S. detector is fully charged and operational....."
"Vaccinating billions of people to prevent a disease with a 99% survival rate for people under 70 — all based on clinical trial efficacy analysis of less than 200 COVID-19 cases involving patients with coughs and unreliable PCR tests with significant false positive rates — is not the triumph of science. It’s corruption and it’s the tip of the iceberg."
” Bottom line: COVID-19 is too rare and too benign to permit analysis of exactly the kind of serious health outcomes that most Americans believe the vaccine will “cure.”...
"The BMJ author, associate editor Peter Doshi, pointed out that none of the trials underway “are designed to detect a reduction in any serious outcome such as hospital admissions, use of intensive care, or deaths. Nor are the vaccines being studied to determine whether they can interrupt transmission of the virus.”
This is in stark contrast to how the trials have been marketed to the public as assessing the vaccine’s impact on preventing severe COVID-19 illness, hospitalizations and deaths."
“laboratory confirmed infections even with only mild symptoms qualify as meeting the primary endpoint definition. In Pfizer and Moderna’s trials, for example, people with only a cough and positive laboratory test” qualify as COVID-19 positive cases. Astra Zeneca’s paused COVID-19 vaccine trial allowed a mere cough and fever with a positive PCR test to qualify as a positive case. Final efficacy analyses are planned after vaccine trial officials document a measly 150-160 “events” (positive indications of symptomatic COVID-19, regardless of illness severity)."
"-cannot tell you how long the alleged protection of COVID-19 vaccines will last.
–has zero data on young children’s response to their warp speed-produced jabs, even as schools across the globe prepare to mandate it as a condition of access to education.
–can’t tell you about the synergistic effects of the COVID-19 vaccine with other vaccines.
–Nor can Big Pharma tell you about the long-term side effects of its “miraculous” shots. (And don’t forget the astonishing fact that vaccine makers are immune from lawsuits by vaccine-injured Americans.)"
________________________________________________________________________
Trials Are Merely Testing Reduction Of Common Cold Symptoms
Prevention of infection is not a criterion for success for any of these vaccines.
((AS IF THEY COULD ))
Three of the vaccine protocols—Moderna, Pfizer, and AstraZeneca—do not require that their vaccine prevent serious disease.
-only that they prevent moderate symptoms which may be as mild as cough, or headache.
-The first surprise found upon a closer reading of the protocols reveals that each study intends to complete interim and primary analyses that at most include 164 participants.
These companies likely intend to apply for an emergency use authorization (EUA) from the Food and Drug Administration (FDA) with just their limited preliminary results.
Interim analysis success requires a seventy percent efficacy. The vaccine or placebo will be given to thousands of people in each trial. For Moderna, the initial interim analysis will be based on the results of infection of only 53 people. The judgment reached in interim analysis is dependent upon the difference in the number of people with symptoms, which may be mild, in the vaccinated group versus the unvaccinated group.
Moderna’s success margin is for 13 or less of those 53 to develop symptoms compared to 40 or more in their control group. For Johnson & Johnson, their interim analysis includes 77 vaccine recipients, with a success margin of 18 or less developing symptoms compared to 59 in the control group.
For AstraZeneca, their interim analysis includes 50 vaccine recipients, with a success margin of 12 or less developing symptoms compared to 19 in the 25 person control group. Pfizer is even smaller in its success requirements. Their initial group includes 32 vaccine recipients, with a success margin of 7 or less developing symptoms compared to 25 in the control group.
The primary analyses are a bit more expanded, but need to be less efficacious for success: about sixty percent. AstraZeneca, Moderna, Johnson & Johnson, and Pfizer have primary analyses that distribute the vaccine to only 100, 151, 154, and 164 participants respectively. These companies state that they do not “intend” to stop trials after the primary analyses, but there is every chance that they intend to pursue an EUA and focus on manufacturing the vaccine rather than further thorough testing.
The second surprise from these protocols is how mild the requirements for contracted Covid-19 symptoms are. A careful reading reveals that the minimum qualification for a case of Covid-19 is a positive PCR test and one or two mild symptoms. These include headache, fever, cough, or mild nausea. This is far from adequate. These vaccine trials are testing to prevent common cold symptoms.
These trials certainly do not give assurance that the vaccine will protect from the serious consequences of Covid-19. Johnson & Johnson is the only trial that requires the inclusion of severe Covid-19 cases, at least 5 for the 75 participant interim analysis.
One of the more immediate questions a trial needs to answer is whether a vaccine prevents infection. If someone takes this vaccine, are they far less likely to become infected with the virus? These trials all clearly focus on eliminating symptoms of Covid-19, and not infections themselves.
_______________________________________________________________________________
Risk Reduction - Very deceiving -
Moderna announced an effectiveness rate of 94.5 percent for its vaccine. How did the company come to that number? (Note: The trial was designed only to assess symptoms on Day 14 after receiving the vaccine or the placebo – not whether the vaccine prevented infectivity or transmission.)
It’s called risk reduction. Moderna’s trial included 30,000 total participants, so approximately 15,000 participants were in each section of the trial (the vaccine section and the placebo section). Moderna reports that in the “vaccine” arm of the trial, only five people (0.03 percent) got symptoms on Day 14
In the “placebo” arm, 90 people (0.6 percent) got symptoms on Day 14. Therefore, the actual symptom-reduction benefit of this injected drug is 0.57 percent (0.6 percent minus .03 percent equals .57 percent).
Where did they get the headline of 94.7 percent reduction, passing the magic threshold of 90 percent for fast-track approval? They added five (from five vaccine participants who had symptoms) to 90 (90 placebo participants who had symptoms) to get 95. Ninety is 94.7 percent of 95, so with the magic of risk reduction, we have a successful “vaccine” trial.
Pfizer’s effectiveness rate was reported as both 90 percent and 95 percent. These numbers were calculated in the same way at Moderna’s number. Astonishingly, all drugs’ effective rates are calculated in this way, rather than in absolute numbers. Again, the absolute number for the Moderna trial indicates that the experimental vaccine — subjected to no long-term studies — was only .57 percent more effective than the placebo at reducing or preventing symptoms of illness at Day 14 after injection. It’s unclear whether the symptoms that were reported had anything to do with COVID or with side-effects of the vaccine.
About the Trials
[ The studies are not designed to detect a reduction in outcomes such as severe illness, hospitalization or death.
For individuals who develop severe symptoms, the vaccine is not a remedy. ]
Participants in every Covid-19 vaccine trial have reported adverse reactions including high fever, chills, muscle pains and headaches.
Some have even reported severe reactions that required hospitalization and invasive treatment.
According to the FDA, potential long-term effects may include Guillain-Barré syndrome, brain swelling, muscle weakness and paralysis, convulsions and seizures, stroke, narcolepsy, shock, heart attack, autoimmune disease, arthritis and joint pain, multisystem inflammatory syndrome in children, and death. Again, some UK health workers have experienced anaphylactic shock after receiving one dose of the….
[[[around 20 or more people died in the Moderna/Pfizers challenge studies, I dont know why everyone is calling these clinical trials]]]
The vaccines aren’t designed to prevent COVID.
An FDA Pfizer briefing paper published December 10, 2020, revealed 43 percent more suspected cases of Covid-19 in the vaccinated group than in the placebo group within seven days of vaccination. They will also not end restrictions. Dr. Anthony Fauci of the National Institutes of Health acknowledges that the vaccines may prevent symptoms but will not block spread of the virus, so vaccine recipients will still need to wear masks, practice social distancing and avoid crowds.
Given these issues, is the vaccine even necessary? According to the CDC’s current best estimate, the “infection fatality rate” (IFR) for Covid-19 is less than 1 percent for people age 69 and younger, including a .003 percent IFR for children and adolescents.
Safety WHAT SAFETY
- First case of postmortem study in a patient vaccinated against SARS-CoV-2 - A previously symptomless 86-year-old man received the first dose of the BNT162b2 mRNA COVID-19 vaccine. He died 4 weeks later from acute renal and respiratory failure. Although he did not present with any COVID-19-specific symptoms, he tested positive for SARS-CoV-2 before he died. ....Acute bronchopneumonia and tubular failure were assigned as the cause of death at autopsy; however, we did not observe any characteristic morphological features of COVID-19. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051011/
_________________________________________________
No Long-Term Safety Studies
Absolutely no long-term safety studies have been conducted on any of these vaccines. The following numbers come from the FDA’s Vaccines and Related Biological Products Advisory Committee in its meeting on Dec. 10 to review the Pfizer vaccine:
Less than 2.1 percent of the safety study cohort had been followed for more than three months as of the Nov. 14 cutoff date. This is inadequate to determine any long-term effects of the vaccine. If the manufacturers allow vaccination of the placebo group after six months, longer follow up of the early cohorts will be lost.
Only 2.1 percent and 1.8 percent of the study cohort included patients 75 years old and older with pre-existing medical conditions, for the vaccinated and the placebo groups, respectively. There were only 41 total African Americans older than 75 in both arms of the Pfizer vaccine study. These are insufficient samples on which to base broad recommendations for these very important and vulnerable segments of the population.
Even pro-vaccine doctors are expressing serious doubts:
In November 2020, Dr. Peter Jay Hotez said of the new mRNA vaccines: “I worry about innovation at the expense of practicality because they [the mRNA vaccines] are weighted toward technology platforms that have never made it to licensure before.”
Hotez is a major proponent of vaccines and is a Professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine, where he is also Director of the Texas Children’s Hospital Center for Vaccine Development.
Michal Linial, PhD is a Professor of Biochemistry. Because of her research and forecasts on COVID-19, Dr. Linial has been widely quoted in the media. She recently stated, “I won’t be taking it [the mRNA vaccine] immediately – probably not for at least the coming year. We have to wait and see whether it really works. We will have a safety profile for only a certain number of months, so if there is a long-term effect after two years, we cannot know.” (Is “two years” really sufficient time to assess a “long-term effect”?)
It’s also worth noting that Moderna’s preliminary safety data suggested that patients in the mRNA-1273 trial were more likely to experience systemic adverse events — clinical-trial lingo for “difficult side effects” — after a second dose of the vaccine. Again, vaccine-trial candidates are screened for any chronic health issues, such as asthma, allergies, autoimmune diseases — they are the healthiest people in the population at large. How will people who do have chronic issues, even mild ones such as allergies, respond to these vaccines?
__________________________________________________
How are the COVID vaccines different from other vaccines on the market? Dr Tom C.
The COVID vaccines are mRNA (messenger RNA) vaccines, which are completely new. No mRNA vaccine has ever been licensed for human use before. There are no other therapies or prophylactics on the market that use the same approach, despite a handful of efforts.
Traditional vaccines introduce pieces of a virus (“live” or inert), as well as adjuvants such as aluminum and mercury, to stimulate an immune reaction.
The new mRNA vaccine is completely different. It actually injects (transfects) molecules of synthetic genetic material from non-human sources into our cells. Once in the cells, the genetic material interacts with our transfer RNA (tRNA) to make a foreign protein that supposedly teaches the body to destroy the virus being coded for. So the vaccine is hijacking the protein-makeup machinery.
Note that these newly created proteins are not regulated by our own DNA, and are thus completely foreign to our cells. What they are fully capable of doing is unknown.
The Moderna vaccine is given in two doses, 28 days apart. The Pfizer vaccine will require two shots, three weeks apart.
The Pfizer and Moderna vaccines also include the traditional toxic adjuvants.
What are safety concerns?
Antibody Dependent Enhancement: “Exaggerated Immune Reaction”
A major concern being voiced by scientists and physicians (including the ex-Pfizer head of respiratory research Dr. Michael Yeadon and the lung specialist and former head of the German public health department Dr. Wolfgang Wodarg) has to do with the potential for antibody-dependent enhancement (ADE), a phenomenon documented in humans, non-human primates, and ferrets in connection with the coronaviruses linked to SARS and MERS. In ADE, vaccines can cause antibodies present in a person’s body to act like a Trojan horse for wild viruses.
In the case of individuals receiving COVID-19 vaccines, ADE could not only end up enhancing disease severity but could also lead to organ damage. Of concern, COVID-19 vaccine trials are not designed to detect ADE. It is not known what proportion of the U.S. population might suffer pathogenic priming or ADE after receiving a COVID-19 vaccine, but the estimated 15 to 24 million Americans who already have an autoimmune disease could be particularly susceptible. The CDC has indicated that individuals with high-risk medical conditions—individuals excluded from the Phase I trials—are one of the proposed groups for early vaccination.
Damaging Our DNA
The vaccine trials have not ruled out whether the new genetic material they will insert into human bodies are homologous (the same) as other genetic sequences in the body. If homologous sequences are present, the body will be “taught” to attack itself.
If this seems an unlikely occurrence, consider these facts. A BLAST search is a way to search the compiled genetic data bank for all human and microbial sequences. A BLAST search for one of the sequences (called the Rd-Rp sequence) being used in the RT/PCR tests (which are being used to diagnose the presence of the coronavirus) reveals that there are 99 human genetic sequences with a 100 percent sequence-identity match. Another sequence (called the Orf1ab sequence) being used in the PCR test returns 90 results with a 100 percent sequence-identity match.
In addition, doing a BLAST search reveals 92 microbes identical to the Or1ab sequence and 100 microbes identical to the RdRp sequence. These sequences are being used in the PCR tests because they are identified as being part of the coronavirus. It’s logical to assume that these genetic sequences — as well as others —are in the vaccines as well. The response could be either an acute inflammatory response or, later in life, the development of an autoimmune disease.
(Side note: That the PCR tests are searching for genetic sequences innate in the human body means that the PCR testing for the SARS CoV2 virus has no scientific validity as it is not testing for any sequence that is UNIQUE to any virus. This explains why so many people test positive and have few or no symptoms of illness).
PEG - polyethylene glycol
" ... FDA has labeled PEG as “biologically inert/inactive,” investigators are now questioning its biocompatibility and warning about PEGylated particles’ promotion of tumor growth and adverse immune responses that include “probably underdiagnosed” life-threatening anaphylaxis. .."
The mRNA vaccines from Pfizer and Moderna contain polyethylene glycol (PEG). The reason is that the mRNA molecule is vulnerable to destruction. To protect the fragile mRNA strands while they are being inserted into our DNA, they are coated with PEGylated lipid nanoparticles. This coating hides the mRNA from our immune system, which ordinarily would kill any foreign material injected into the body. PEGylated lipid nanoparticles have been used in several drugs for years. Because of their effect on immune system balance, they have been shown to induce allergies and autoimmune diseases, according to several studies. Additionally, PEGylated lipid nanoparticles have been shown to trigger their own immune reactions, and to cause damage to the liver.
PEG is not only a potential allergen, it is also a suspected carcinogen. Moderna’s 2018 corporate prospectus acknowledges that “there can be no assurance that our LNPs (lipid nanoparticles) will not have undesired effects,” including reactions that “could lead to significant adverse events.”
Media outlets are reporting that two individuals who received the Pfizer-BioNTech COVID-19 mRNA vaccine developed severe anaphylactic reactions following the injection. Reuters reported on Dec. 10 that an investigation into the anaphylactic reactions has identified PEG as the likely culprit. It was also reported that PEG is not in other types of vaccines.
According to these news reports, documents published by the two companies showed that people with a history of severe allergic reactions were excluded from the clinical trials. Therefore, this life-threatening adverse safety signal did not appear in their clinical trial safety data.
Although the FDA has labeled PEG as “biologically inert/inactive,” investigators are now questioning its biocompatibility and warning about PEGylated particles’ promotion of tumor growth and adverse immune responses that include “probably underdiagnosed” life-threatening anaphylaxis. These undesirable responses have, on occasion, halted clinical trials. As a result, some scientists argue that it is time to develop alternatives to replace PEG.
American and Dutch researchers declared in 2013:
“[T]he accumulating evidence documenting the detrimental effects of PEG on drug delivery make it imperative that scientists in this field break their dependence on PEGylation.”
A 2016 study in Analytical Chemistry reported detectable and sometimes high levels of anti-PEG antibodies (including first-line-of-defense IgM antibodies and later stage IgG antibodies) in approximately 72% of contemporary human samples and about 56% of historical specimens from the 1970s through the 1990s. Of the 72% with PEG IgG antibodies, 8% had anti-PEG IgG antibodies > 500ng/ml., which is considered extremely elevated. Extrapolated to the U.S. population of 330 million who may receive this vaccine, 16.6 million may have antibody levels associated with adverse effects.
The researchers confessed that the results were entirely unexpected. The authors concluded that:
The population’s increased exposure to PEG-containing products makes it “natural to assume” that anti-PEG antibodies will continue to be widespread.”
Moderna documents and publications indicate that the company is well aware of safety risks associated with PEG and other aspects of its mRNA technology. In the corporate prospectus supporting Moderna’s stock market launch in late 2018, the company was frank that its technical approach has numerous risks.
Specifically, Moderna acknowledged the potential for its proprietary lipid nanoparticles (LNPs) and PEG to produce “systemic side effects,” given the scientific literature’s documentation of these types of side effects for other LNPs. In comments not generally seen by the public, Moderna stated (p. 33):
[T]here can be no assurance that our LNPs will not have undesired effects. Our LNPs could contribute, in whole or in part, to one or more of the following: immune reactions, infusion reactions, complement reactions, opsonization reactions, reactions, antibody reactions . . . or reactions to the PEG from some lipids or PEG otherwise associated with the LNP. Certain aspects of our investigational medicines may induce immune reactions from either the mRNA or the lipid as well as adverse reactions within liver pathways or degradation of the mRNA or the LNP, any of which could lead to significant adverse events in one or more of our clinical trials.
Addressing the efficacy side of the equation, a mid-2019 study by authors who “are or have been employees of Moderna, Inc. and receive salary and stock options from Moderna, Inc.” further admitted that anti-PEG antibodies “present significant challenges to the clinical efficacy of PEGylated therapeutics and will require strategies to overcome [their] effects.”
Cancer Risk
The Vaccines and Related Biological Products Advisory Committee (VRBPAC) is the U.S. Food and Drug Administration’s (FDA) internal panel that licenses new vaccines as “safe and effective,” and that approved the Pfizer vaccine for emergency use.
In a 2012 VRBPAC meeting, panelists voted unanimously to allow use of human tumor cells in vaccines. The FDA allows both human fetal cells and adult human tumor cells in vaccines. Both types have cancer risks. While both Pfizer and Moderna tested their mRNA vaccine using fetal cells, there are no fetal cells, cell debris or DNA in their final products.
However, according to company documents, Johnson and Johnson (Janssen) and Altimmune’s COVID vaccines are manufactured in the human fetal cell line PER-C6, and thus the final vaccine products will contain cellular debris and DNA fragments from these cells. Researchers harvested these cell lines from the eyeball of an 18-week-old human fetus aborted in 1985, and then rendered them immortal by making them cancerous.
The AstraZeneca, Cansino, Gamayela, Vaxart, LongComm and Upitt vaccines are manufactured in the human fetal cell line HEK293, and thus the final vaccine products will contain cellular debris and DNA fragments from the fetal HEK-293 cell line. Scientists harvested this cell line from the kidney of a female Dutch fetus legally aborted in 1973 and then immortalized the cells by rendering them cancerous.
According to FDA’s “The Pink Sheet” dated Nov. 29, 1999, for two decades the agency has been acutely aware of the inherent risks of using immortalized cell lines for vaccine development. The FDA Center for Biologics Evaluation and Research Director Dr. Peter Patriarca explained that continuous cell lines are used for their ability to self-propagate, making them an ideal substrate on which to grow viruses. “The worst thing we are concerned about is … malignancy, because some of these continuous cells have the potential for growing tumors in laboratory animals.”
Patriarca further conceded that “the technology to make these vaccines actually exceeds the science and technology to understand how these vaccines work and to predict how they will work.” This dire “black box” conundrum that Patriarca described in 1999 is even more acute today with the urgent pressure to develop COVID vaccines before manufacturers have tested them in animals or subjected them to long-term safety studies.
Antibody-dependent enhancement (ADE),
COVID-19 vaccine trials are not designed to detect ADE https://pubmed.ncbi.nlm.nih.gov/33077678/
Estimated 15 to 24 million Americans
PEGS
Analytical Chemisty Report
Increased exposure to Pegs
Moderna documents ...well aware of safety risks associated with PEG and other aspects of its mRNA technology
Moderna stated (p. 33):
LNPs undesired effects
“present significant challenges to the clinical efficacy of PEGylated
human fetal cells
Pfizer and Moderna tested their mRNA vaccine using fetal cells,
FDA’s “The Pink Sheet”
About the Trials https://www.bmj.com/content/371/bmj.m4037
reported adverse reactions https://www.nejm.org/doi/full/10.1056/NEJMoa2022483
reported severe reactions
hospitalization and invasive treatment.
-death-
UK health workers
FDA Pfizer briefing paper
Will not block spread of the virus,
CDC’s current best estimate,
Moderna have sold tens of millions of dollars of the company’s stock
from a presentation that’s
CNBC reports
15 to 24 million Americans who already have an autoimmune disease
( The animal trials for "corona virus"
– In 2012 ferrets became sick and died. And, in this study mice and ferrets developed lung disease.
– In 2016 this study also produced lung disease in mice. )
Multiple countries in Europe have put further administration of the COVID vaccine on hold ...
Including France, Germany & Italy Suspend AstraZeneca COVID Vaccine
Netherlands, The Irish Republic, Denmark, Norway, Bulgaria and Iceland have also temporarily halted inoculations with the vaccine, while the Democratic Republic of Congo and Indonesia have postponed the launch of their rollouts. (so has Japan - Japan said they would conduct their own tests)
Several European countries, including Austria, have suspended the use of certain batches of the drug as a precautionary measure.
-Indian sources showed that AstraZeneca COVID-19 Vaccine is Only 8 percent Effective In the Over 65’S.
It appears the nation of India are not as gullible as others and their due diligence in asking difficult questions of Big Pharma triggered Pfizer to go Into full COVID Vaccine Retreat After India Demands More Data.
[[ " The US-based drug-maker, Pfizer says it has withdrawn a request to have its Covid-19 vaccine authorized for use in India. The company has promised to resubmit the application once it gathers more data. " - .... a government source saying that Pfizer wanted a clinical trial waiver for its vaccine, developed jointly with the German firm BioNTech, but the regulator has insisted on a bridging study in India. The experts wanted to see how the vaccine would work among the Indian........ “ https://principia-scientific.com/pfizer-in-covid-vaccine-retreat-after-india-demands-more-data/ ]]
It is not surprising that it is frontline medical workers who are conspicuous among a new pandemic – vaccine refusers. Last week we reported that French Healthcare Workers are Rebelling Against Covid Vaccine En Masse.
"....around “half of health workers in French care homes do not want to be vaccinated”
“There’s a complete loss of trust,”
"Among people in the U.K., 35 cases of deafness and 25 cases of blindness have been reported by people who have taken the experimental mRNA COVID-19 vaccines. "
________________________________________________
Do health authority vaccine claims constitute deceit?
Health authorities around the world continue to claim that COVID-19 vaccines are “safe.” However, according to the Collins dictionary, this means that:
“Something that is safe does not cause physical harm or danger.”
“Safe” claims are routinely made by organizations like the UK NHS, the Centers for Disease Control in the USA and the World Health Organization.
A search we carried out of the VAERS database in the U.S. shows that nearly 8,000 adverse events have been reported to date (note: as many as 90% of adverse reactions often go unreported), and over 1.5% of these involved death. It is then arguably deceitful to refer to these experimental vaccines as “safe.”
Information chasm-
Even if it can be argued that the existing safety claims, advertising campaigns or pressure from some sectors of the health professions are neither coercive nor deceitful, it is this last prerequisite concerning the provision of information where mass vaccination programs typically fall short.
Given the lack of vaccine transparency, vaccinators themselves are not properly informed so are generally not in any position to offer accurate information that might be available in the public domain, but is generally not well known.
Information that should be freely communicated includes the fact that the vaccines are experimental and unproven. Those considering giving consent should be told about the vaccines’ reliance on synthetic biology that has never been tested at scale. But it also includes information on known risks and benefits from Phase 3 trials, and that these trials are still under way and some won’t be complete for over 18 months (e.g. Jan. 31, 2023, for Pfizer mRNA vaccine).
Put simply – without vaccine transparency, informed consent is just not possible.
____________________________________________________________________
Doctors in Europe are demanding answers, and if not, "we demand that approval for use of the gene-based vaccines be withdrawn"....
"....the approval of the COVID-19 vaccines by the EMA was premature and reckless, and that the administration of the vaccines constituted and still does constitute “human experimentation”, which was and still is in violation of the Nuremberg Code."
_______________________________________
Researchers are urging caution when it comes to the use of adenovirus type-5 (Ad5) vectored vaccines for COVID-19.
Disturbingly, a group of researchers are now expressing concern that some COVID-19 vaccine candidates might put certain people at a higher risk of acquiring HIV, the virus that causes AIDS.26,27,28 Using the failed attempt to create an HIV vaccine as an example, researchers explain29 that the genetically engineered adenovirus, Ad5, used in the HIV vaccine trials, is the same one being used now in four COVID-19 candidates being studied in the U.S., Russia and Pakistan. At the time of the failed HIV vaccine, scientists were unable to identify the exact reason why Ad5 seemed to increase the risk of HIV; it just inexplicably did. Interestingly, Dr. Anthony Fauci was the lead author on the HIV study,30 in which he questioned “whether the problem extends to some or all of the other recombinant vectors currently in development or to other vector-based vaccines.” Reflecting on that question, the researchers say they decided to go public with this information now, because Ad5 vaccines for COVID-19 might soon be tested in populations with high HIV prevalence, and they believe that informed consent about the HIV/AIDS risk should be part of the COVID-19 clinical studies. https://principia-scientific.com/covid-19-vaccine-trials-rigged-to-pass-efficacy-test/
COVID-19 RNA Based Vaccines And The Risk Of Prion Disease
One such potential adverse event is prion based diseases caused by activation of intrinsic proteins to form prions. A wealth of knowledge has been published on a class of RNA binding proteins shown to participating in causing a number of neurological diseases including Alzheimer’s disease and ALS. TDP-43 and FUS are among the best studied of these proteins [2]. The RNA sequence in the vaccine [3] contains sequences believed to induce TDP-43 and FUS to aggregate in their prion based conformation leading to the development of common neurodegerative diseases. In particular it has been shown that RNA sequences GGUA [4], UG rich sequences [5], UG tandem repeats [6], and G Quadruplex sequences [7], have increased affinity to bind TDP-43 and or FUS and may cause TDP-43 or FUS to take their pathologic configurations in the cytoplasm. In the current analysis a total of sixteen UG tandem repeats (ΨGΨG) were identified and additional UG (ΨG) rich sequences were identified….. Binding to certain RNA sequences when the proteins are in the cytoplasm is believed to causes the molecules to fold in certain ways leading to pathologic aggregation and prion formation in the cytoplasm [2]. The current analysis indicates Pfizer’s RNA based COVID-19 vaccine contains many of these RNA sequences that have been shown to have high affinity for TDP-43 or FUS and have the potential to induce chronic degenerative neurological diseases… Another related concern is that the Pfizer vaccine uses a unique RNA nucleoside 1-methyl-3′-pseudouridylyl (Ψ). According to FDA briefing documents, this nucleoside was chosen to reduce activation of the innate immune system [12]. RNA molecules containing this nucleoside will undoubtedly have altered binding [13]. Unfortunately, the effect on TDP-43, FUS and other RNA binding proteins is not published. The use of this nucleoside in a vaccine can potentially enhance the binding affinity of RNA sequences capable of causing TDP-43 and FUS to assume toxic configurations… https://principia-scientific.com/covid-19-rna-based-vaccines-and-the-risk-of-prion-disease/
Vaccine Makers Can’t Be Held Liable for Injuries or Death
The National Childhood Vaccine Injury Act (NCVIA) of 1986 was signed into law by United States President Ronald Reagan as part of a larger health bill on November 14, 1986. NCVIA’s purpose was to eliminate the potential financial liability of vaccine manufacturers due to vaccine injury claims to ensure a stable market supply of vaccines. By 1985, vaccine makers were having trouble getting insurance coverage because of risks associated with the DPT vaccine, so they appealed to Congress for help. This act is the result. Therefore, if you or anyone you know is injured or killed by the vaccine, you or they or family members can’t sue the manufacturer.
However, these companies profit richly from these vaccines while being sheltered from paying for any failures. Even more astonishing, the Moderna vaccine is using hundreds of millions in taxpayer monies for research and will keep whatever profits they make.
Warp Speed Vaccine Will Be Shielded From Liability
__________________________________________
Coronavirus vaccine deaths NOT covered by life insurance
____________________________________________
It is interesting to note that no RCTs on the lockdown policies, known to cause extreme harm, were conducted before being forced upon us. ( -Vaccines in general are not required to undergo long-term double-blind inert-placebo controlled trials to assess safety. ) RCTs
Opposition to these therapies makes no sense medically or scientifically. Unfortunately it does make sense financially. First they are all inexpensive and easily available, which threatens the staggering profits being made by the vaccine producers. Second, and this is quite astonishing, it is illegal to grant emergency use authorization to a drug if there are other safe and effective treatments available. Draw your own conclusions from this.
– Has a one sided campaign of censorship, character assassination, suppression of legitimate information and open discussion, and dissemination of false and misleading information been used to create an environment of fear?
________________________________
Legal Advice If You Are Pressured Into Taking A Risky COVID Vaccine
Experimental biological agents
Correct language is ‘critical’: Not COVID-19 ‘vaccines,’ but experimental biological agents-
"Dr. Gold insists that even the designation of the new products as vaccines is inapprorpriate.
“Definitely you should not be calling this the ‘COVID-19 vaccines,’” she says. “The reason is, whatever you call it, it’s experimental. It’s not been approved as a vaccine. It’s currently in its investigational stage.” It means you have enrolled yourself in a medical trial …
Experimental vaccines are ‘not safer’ than the Wuhan Virus…
AFLD (America's Frontline Doctors) then drew from common sense to conclude that taking an experimental vaccine “is not safer” than a very low IFR for the Wuhan..."
-----------------
– What are the long-term risks of these vaccines?
https://www.lewrockwell.com/2021/05/gary-g-kohls/no-jab-for-me-and-here-are-35-reasons-why/?fbclid=IwAR10EUSoDGCzGs1hvR7d-UetM1zF2ylnIeDULSO0WTamtbYCtyTMiuoXaHw
___________________________________________
["the heads of the Ministry of Health and the Prime Minister presented the vaccine in Israel and began vaccinating Israeli residents, the vaccinated have not been informed, that in practice they are participating in a medical experiment and that their consent is required for this purpose under the Nuremberg Code,"]
The International Criminal Court in The Hague has accepted the complaint of violation of the Nuremberg Code by the Israeli government.
_________________________________________________________________
How are the COVID vaccines different from other vaccines on the market?
https://drtomcowan.com/covid-vaccines-are-medical-experiments-on-humanity/
People, including mainstream “scientists” and “experts,” do not realize that vaccines, mRNA-based or otherwise, have never been tested for their efficacy. To test the efficacy for developing and testing the vaccines, the virus (SARS-CoV-2) must be available in pure isolated form. This is not only a scientific requirement but simple logical consideration as well. It is impossible to establish the usefulness and effectiveness of the vaccines without the use or presence of the target, i.e., the virus. It is a commonly known fact now that no purified isolated specimen of the virus is available anywhere in the world. Therefore, no one can test the efficacy of the vaccines, and it has not been done either. Saying it otherwise is simply a lie. The development of vaccines is based on testing against the PCR test, which is not a test for the virus but an RNA/DNA-based marker of the unknown or imaginary virus (commonly known as SARS-CoV-2). The PCR test is an arbitrary “dipstick” type test without any link to the virus, infection, or illness. As the virus has never been isolated, it is impossible to link the marker to it and validate the PCR test for its relevancy and accuracy as well. Testing and assessing viruses and their link to illnesses and the treatments, as currently described and promoted, reflect ignorance and incompetency of the “experts” and “scientists.” Therefore, the medical and pharmaceutical areas require urgent scrutiny and audit of their scientific claims. The focus should be treating the illness/infection, if and when it occurs, and not developing the treatments (such as vaccines) for the imaginary virus and its mutants.
_____________________________
They should have tried to fudge the numbers more than 99.8% SURVIVAL RATE IF ANY, if they plan to get away with all this .....
“87,000 Doctors & Nurses Refuse COVID19 Vaccine." Just in the Nethelands alone.
This is from an analysis I did last year-
Systemic Adverse Reactions (SARs) -the IRONY is tempting.
30-40% Had Systematic adverse events, which I'm understanding can lead to issues. A somewhat bias reviewer on the side of vaccines stated he does not have enough info to make a decision for himself even, they hid some of the data, didn't release some of the data. Some left the study were not able to continue, also some conditions were unknown ....
From An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
NEW ENGLAND JOURNAL OF MED. (my comments)
"""Solicited adverse events that occurred in more than half the participants included fatigue, chills, headache, myalgia, and pain at the injection site. Systemic adverse events were more common after the second vaccination, particularly with the highest dose, and three participants (21%) in the 250-μg dose group reported one or more severe adverse events.
-Side effects grew more common with more (and larger) injections, the scientists write:"""
"Systemic adverse events were more common after the second vaccination, (and we would all be looking at a second shot)
particularly with the highest dose, and three participants (21%) in the 250-μg dose group reported one or more severe adverse events." -(higher does for elderly)
After the first vaccination, solicited systemic adverse events were reported by 5 participants (33%) in the 25-μg group, 10 (67%) in the 100-μg group,
(I MAY BE UNDERSTATING DANGERS)
and 8 (53%) in the 250-μg group; all were mild or moderate in severity (Figure 1 and Table S2).
- Solicited systemic adverse events were more common after the second vaccination and occurred in 7 of 13 participants (54%) in the 25-μg group,
-all 15 in the 100-μg group, (AVERAGE - dosing)
-and all 14 in the 250-μg group, with 3 of those participants (21%) reporting one or more severe events.
The two-dose vaccine series was generally without serious toxicity; systemic adverse events after the first vaccination, when reported, were all graded mild or moderate.
(NEJM)
https://www.nejm.org/doi/full/10.1056/NEJMoa2022483...
----
-and BECAUSE OF THIS, THE STANDARDS ARE IF LESS THAN HALF ( "more than half " -HAVE TO HAVE LESS THAN A SEVER REACTION TO CONTINUE?!?!
A Systemic adverse or Severe ADVERSE event they continue the TRIAL and mess up some more?!?!
That means 40% of the population can deal with it??!?!?!
----------------------------------------------------------
"FDA is now willing to license COVID vaccines with a dismal 50%—and as low as 30%—efficacy."
----------------------------------------------------------
Systemic effects:
{{{There 40% Moderate / Systematic Adverse Events in the average dose range after the recommended, in the recommended dosing level especially......, lets talk about this.. }}}
Several Classifications of Systemic Adverse Reactions (SARs) during allergen immunotherapy have been proposed, but the comparison of their usefulness in daily clinical practice is lacking.
https://www.sciencedirect.com/science/article/abs/pii/S2213219818308262?fbclid=IwAR2YtRjMsAylVHywtKZ_ZjWSlF50erri2dAY9Rpt4YUdeaMiVFMUmRFVfHA
Systemic Reaction Throughout the Body
By Rod Brouhard, EMT-P Medically reviewed by Michael Menna, DO on November 18, 2019
Low Section Of Woman With Hives
Kunnapat Jitjumsri / EyeEm / Getty Images
When a reaction stays with one area of the body, it's known as a localized reaction. When inflammation spreads from a localized area of one organ (like the skin) to other organ systems in the body, it's known as a systemic reaction. The inflammation can be from toxins, allergies or infections.
Anaphylaxis- (Allergies)
Anaphylaxis is a systemic reaction related to allergies. It occurs when an allergic reaction moves from a single organ system (most commonly the integumentary system, which is the skin) to include at least one other system.1 Anaphylaxis often affects the respiratory system (shortness of breath) or the circulatory system (low blood pressure/shock) in addition to the integumentary system (itching, redness, and hives). Anaphylactic shock is a life-threatening, systemic allergic reaction characterized by dangerously low blood pressure.
Sepsis- (Infection)
When an otherwise low-key bacterial infection develops into a full-body failure of organs, it's known as sepsis or septic shock. As healthcare providers learn more about sepsis and more about how we can treat it, recognition of this systemic disorder becomes increasingly important.2Sepsis usually starts out as a common infection with typical signs and symptoms. Eventually, sepsis evolves into fatigue, confusion, no fever, weakness and progresses to low blood pressure.
Toxins-
Poisons or toxins often cause localized rashes or swelling. However, if they are picked up in the bloodstream or otherwise transported around the body, some toxins can cause reactions in areas far away from where the substance entered the body. Carbon monoxide poisoning, for example, shows signs and symptoms throughout the body.3 Fatigue, weakness, confusion, headaches, and nausea are all symptoms. In extreme cases, carbon monoxide poisoning can make the patient's skin very red.
Treatment
There is no specific treatment for a systemic reaction. It is dependent on the type of reaction (allergic, toxic or septic). The important thing is to recognize a systemic reaction quickly and to seek help immediately. Not all systemic reactions are life-threatening, but when infection or a substance can affect so many different organ systems at the same time, chances are the outcome will not be desirable. It is important to avoid the known causes of reaction.
is important to avoid the known causes of reaction.
If you suspect a patient (or you) is experiencing a systemic reaction, head to the doctor or call 911 immediately. Try not to drive if you are experiencing symptoms of fatigue, confusion, dizziness or weakness. You might discover that you're not able to operate a motor vehicle safely for you or for others on the road.
https://www.verywellhealth.com/systemic-reaction-1298693
Morphologic assessment of systemic effects --
-- Systemic effects:
are defined as those effects occurring in tissues distant from the site of contact between the body and the medical device or biomaterial. Systemic effects can be associated with leachable chemicals or degradation products released from a medical device following exposure to biological fluids and/or inflammatory cells.
Mechanisms associated with systemic effects include:
-Chemical toxicity, (For example, chemicals might:
Themselves be toxic or require metabolism (chemical change within the body) before they cause toxicity
Cause damage leading to fibrosis as the body attempts to repair the toxicity.
Damage or disrupt an enzyme system or protein synthesis.
Produce reactive chemicals in cells.
Cause changes in hormone signaling or other effects.
Produce DNA damage or epigenetic changes {Produce DNA damage or epigenetic changes } https://toxtutor.nlm.nih.gov/03-001.html) ..... http://www.toxmsdt.com/0-toxtutor-home.html
more on epigenetics in the following...
Epigenetics was described as all the stuff we dont know about Genes........interesting...
-Non-specific Cytokine activation (with Inflammation) --( Cytokines are regulators of host responses to infection, immune responses, inflammation, and trauma. Some cytokines act to make disease worse (proinflammatory cytokines), whereas others serve to reduce inflammation and promote healing (anti-inflammatory cytokines...
https://www.sinobiological.com/resource/cytokines/inflammatory-cytokines?fbclid=IwAR3L8K3AK2Tl97L7AJlWAJCPbv8Kkyfa8c7-B0wHXvNXjQT3oVqZ90D_iUs
-Vasoactive effects associated with complement activation,
-Complement activation --
............In this immediate hypersensitivity reaction, the antigen binds to an IgE antibody on mast cells or basophils, causing release of mediators that produce life-threatening symptoms - or "Anaphylaxis"
--"Anaphylaxis" --
What is anaphylaxis?
This term is used to describe a severe allergic reaction that involves the respiratory and/or cardiovascular systems. Anaphylaxis is the most severe form of an allergic reaction and is life-threatening.
https://www.rch.org.au/allergy/what_is_an_allergy/Allergy/
A severe, potentially life-threatening allergic reaction.
The reaction can occur within seconds or minutes of exposure to an allergen.
{oooh.}
Symptoms include skin rash, nausea, vomiting, difficulty breathing, and shock.
If not treated right away, usually with epinephrine, it can result in unconsciousness or death.
https://www.sciencedirect.com/topics/medicine-and-dentistry/complement-activation?fbclid=IwAR3CuyVqSvK0ygpsWKCIKVEAaUd45BqXhcRB1q8S6cS1ro5BP5xMsRl9VPg
A specific immune-mediated response. (possible T-Cell response)
So its at least on the list.... Acute toxicity refers to adverse effects occurring within 24 h following exposure to the test article. The evaluation of acute toxicity is based primarily on clinical observations and microscopic examination of tissues is rarely performed.
Microscopic evaluation of tissues is an important endpoint in assessing subacute (24 h–28 days),
subchronic (typically 3 months in rodents) or
chronic (6–12 months) systemic toxicity following repeated or continuous exposure to an intact device, device components, or extracts thereof. The rat is commonly used as a test animal for the evaluation of medical device or biomaterial systemic effects.
(so we see WE NEED Long TESTING for people that want
this unnecessary wrench in the monkey kidney)
https://www.sciencedirect.com/.../chem.../systemic-effect
---------------------------------------------------
ALSO RECORDED WERE, Serious Adverse Event (SAE) in human drug trials is defined as any untoward medical occurrence that at any dose
- results in death, - is life-threatening -requires inpatient hospitalization or causes prolongation of existing hospitalization -results in persistent or significant disability/incapacity, -may have caused a congenital anomaly/birth defect, -or requires intervention to prevent permanent impairment or damage.[1]
The term "life-threatening" in the definition of "serious" refers to an event in which the patient was at risk of death at the time of the event; it does not refer to an event which hypothetically might have caused death if it were more severe.
[2] Adverse events are further defined as “Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment.”[2] --
---
SEVERE ADVERSE EVENTS WERE about (%15) for the higher dose. ....
"the trial will require thousands of subjects in order to confirm the safety of the vaccine."
"Many phase 3 studies fail because of incorrect "special dosing" ......
Another special dosing consideration, in this case, is age: the immune functions that decline with age and that are likely to be responsible for the greater risk of severe Covid-19 in older adults may also lead to poor vaccine responses. Will a high-dose Covid-19 vaccine be needed for the effective protection of older adults, as observed with influenza vaccines?
Since they are saying it takes a higher dose for the ELDERLY, also everyone is in the second vaccination category
Ralph Barac - "Vaccines won't work in the Elderly for which this disease is most risky." (80-90%)
IM SURE CHILDREN ARE HIGH RISK OF INJURY WE DONT WANT TO GIVE THEM THIS FOR THE WRONG REASONS---
---------------------------------------------
The clinical significance of SARS-CoV-2 binding and neutralizing antibody titers and their ability to predict efficacy will need to be confirmed." - the scientist
--------------------------------------------------------------------------------
"In the meantime, the validity of the assays for measuring antibody will also need to be documented."
They still dont know if they are detecting antibodies
..... ELISA denotes enzyme-linked immunosorbent assay-----
(THIRD PERSON -->"DENOTES" )
________________________________
TOXICITY -- CONTINUED -- IMPORTANT -
Several Classifications of Systemic Adverse Reactions (SARs) during allergen immunotherapy have been proposed, but the comparison of their usefulness in daily clinical practice is lacking.
https://www.sciencedirect.com/.../abs/pii/S2213219818308262
-
BREAKING: FDA announces 2 deaths of Pfizer vaccine trial participants from “serious adverse events”
https://www.greenmedinfo.com/blog/breaking-fda-announces-2-deaths-pfizer-vaccine-trial-participants-serious-adverse
First Pfizer coronavirus vaccines expected to land on Wednesday
https://www.jpost.com/breaking-news/two-individuals-die-from-pfizer-vaccine-651488
COVID-19 Vaccine Bombshell: FDA Documents Reveal DEATH + 21 Serious Conditions As Possible Adverse Outcomes
https://www.greenmedinfo.com/blog/covid-19-vaccine-bombshell-fda-documents-reveal-death-21-serious-conditions-possi1
FDA Briefing Document:
https://www.fda.gov/media/144245/download
Positive association between COVID-19 deaths and influenza vaccination rates in elderly people worldwide
https://peerj.com/articles/10112/
More than half in FDNY say they’ll refuse COVID-19 vaccine
https://nypost.com/2020/12/05/these-nyc-first-responders-fear-covid-19-vaccine-side-effects/
COVID-19 vaccine recipients will not be exempted from self isolation:
https://www.reuters.com/article/us-health-coronavirus-britain-vaccine/covid-19-vaccine-recipients-will-not-be-exempted-from-self-isolation-the-telegraph-idUSKBN28D353
Cancer risk associated with simian virus 40 contaminated polio vaccine
https://pubmed.ncbi.nlm.nih.gov/10472327/
Which Industry Spends the Most on Lobbying?
https://www.investopedia.com/investing/which-industry-spends-most-lobbying-antm-so/
Warning after two NHS workers have allergic reaction to Pfizer/BioNTech Covid vaccine
https://www.standard.co.uk/news/uk/warning-patients-pfizer-biontech-covid-allergic-reactions-b229762.html?utm_source=upday&utm_medium=referral
COVID-19: Four Pfizer vaccine volunteers develop Bell’s palsy
https://zeenews.india.com/world/covid-19-four-pfizer-vaccine-volunteers-develop-bells-palsy-read-details-here-2329924.html
2019-2020 Preliminary In-Season Burden Estimate
https://www.cdc.gov/flu/about/burden/preliminary-in-season-estimates.htm
Side effects from the COVID-19 vaccine means ‘your body responded the way it’s supposed to,’ experts say
https://www.usatoday.com/story/news/health/2020/12/04/covid-vaccine-side-effects-fatigue-aches-normal/3813934001/
REG 174 INFORMATION FOR UK HEALTHCARE PROFESSIONALS
https://dokumentarac.com/wp-content/uploads/2020/12/Information_for_Healthcare_Professionals_on_Pfizer_BioNTech_COVID-19_vaccine.pdf
Vaccine Safety to Remain Unclear Until Millions Get Their Shots
https://www.bloomberg.com/news/articles/2020-11-17/vaccine-safety-to-remain-unclear-until-millions-get-their-shots
The three groups of people advised not to get the Pfizer COVID vaccine
https://news.yahoo.com/coronavirus-3-groups-advised-not-pfizer-vaccine-114923030.html
AUSTRALIA CANCELS COVID VACCINE TRIAL OVER ‘UNEXPECTED’ FALSE POSITIVES FOR HIV
https://www.zerohedge.com/medical/australia-cancels-covid-vaccine-trial-over-unexpected-false-positives-hiv
Health Advisers Rename ‘Adverse Reactions’ to COVID-19 Vaccine
https://blogs.mercola.com/sites/vitalvotes/archive/2020/12/02/health-advisers-rename-_1820_adverse-reactions_1920_-to-covid19-vaccine.aspx?cid_source=twitter&cid_medium=social&cid_content=twittermercola&cid=20201202__blog
Just this week (August 14 2021) A MARYLAND NURSE'S REPORT ABOUT THE EXPERIMENTAL JAB
"I'VE NEVER SEEN ANYTHING LIKE THIS IN ALL MY LIFE OF PRACTICING MEDICINE"
A Nigerian emigrant in the U.S, Jummai Nache who suffered from blood clots after taking her second shot of Pfizer COVID-19 has had both her legs amputated, and will also have both hands amputated due to the complications. Jummai, who was working as a medical assistant in a clinic in Minneapolis
A government related computer programmer, who works in health care data analytics, believes there are at least 45,000 vaccine-related deaths.
https://principia-scientific.com/whistleblower-at-least-45000-deaths-from-vaccines-in-usa/#comment-56293
